ARIX.L Stock - Arix Bioscience plc
Unlock GoAI Insights for ARIX.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $112,000 | $340,000 | $477,000 | $506,000 | $1.33M |
| Gross Profit | $112,000 | $340,000 | $477,000 | $506,000 | $1.33M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $25.48M | $50.95M | $-142,441,000 | $46.65M | $40.80M |
| Net Income | $-27,575,000 | $-173,113,000 | $395.04M | $-69,685,000 | $36.88M |
| Net Margin | -24620.5% | -50915.6% | 82818.2% | -13771.7% | 2777.0% |
| EPS | $-0.21 | $-1.27 | $2.78 | $-0.54 | $0.29 |
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.
Visit WebsiteEarnings History & Surprises
ARIX.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Sep 25, 2024 | — | — | — | — |
Q2 2024 | Apr 23, 2024 | — | — | — | — |
Q3 2023 | Sep 27, 2023 | — | $0.09 | — | — |
Q2 2023 | Apr 25, 2023 | — | $0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.24 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.63 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.63 | — | — |
Q4 2020 | Dec 31, 2020 | — | $1.39 | — | — |
Q3 2020 | Sep 7, 2020 | — | $1.39 | — | — |
Q4 2019 | Dec 31, 2019 | $0.00 | $-0.27 | -33615.0% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $-0.27 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.14 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.14 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.05 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.05 | — | — |
Q2 2017 | Apr 28, 2017 | — | — | — | — |
Latest News
Frequently Asked Questions about ARIX.L
What is ARIX.L's current stock price?
What is the analyst price target for ARIX.L?
What sector is Arix Bioscience plc in?
What is ARIX.L's market cap?
Does ARIX.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ARIX.L for comparison